Cabaletta Bio, Inc.
Canonical company identity and public leadership record.
- Source reported. 18 claims from 3 sources.
- Not claimed by the company.
- Eval: not assessed.
- Chair
- Not published
- Board
- 6 directorsAlpha calculation. Published seats
- Independence
- 5 of 6Alpha calculation
- Committees
- 2
- Evidence
- 3 sources18 published claims
- Open conflicts
- 0None open
Leadership
5 claims| Person | Role | Since | Status | Evidence |
|---|---|---|---|---|
| Anup Marda | Chief Financial Officer | Current | Source reportedE3 | |
| Arun Das, M.D. | Chief Business Officer | Current | Source reportedE4 | |
| Michael Gerard | General Counsel and Secretary | Current | Source reportedE5 | |
| Steve Gavel | Chief Commercial Officer | Current | Source reportedE6 | |
| Steven Nichtberger, M.D. | Chief Executive Officer and President | Current | Source reportedE7 |
Board
6 claims| Director | Status | Since | Committees | Evidence |
|---|---|---|---|---|
| Catherine Bollard, MBChB, M.D. | Independent | None published | Source reportedE2 | |
| Mark Simon, MBA | Independent | Audit | Source reportedE2 | |
| Richard Henriques, MBA | Independent | Audit, chair; Audit · Chair | Source reportedE2 | |
| Scott Brun, M.D. | Independent | None published | Source reportedE2 | |
| Shawn Tomasello, MBA | Independent | None published | Source reportedE2 | |
| Steven Nichtberger, M.D. | Not independent | None published | Source reportedE2 |
Committees
3 claims| Committee | Chair | Members | Risks assigned | Evidence |
|---|---|---|---|---|
| Audit | Richard Henriques, MBA | Richard Henriques, MBA, Mark Simon, MBA | Not described in the published record | Source reportedE8 |
| Audit · Chair | Not published | Richard Henriques, MBA | Not described in the published record |
| Fact | Stated value | Evidence |
|---|---|---|
| Committee appointment | Richard Henriques, MBA: chair, Audit | Source reportedE8 |
| Committee appointment | Mark Simon, MBA: member, Audit | Source reportedE8 |
Financial context
1 claim| Fact | Stated value | Evidence |
|---|---|---|
| Security listing | CABA (NASDAQ) | Source reportedE1 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Legal name | Cabaletta Bio, Inc. | Source reportedE1 |
| Entity status | Public listing published | Source reportedE1 |
| Published fact | US | Source reportedE1 |
Evidence
8 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Alpha canonical company public projectionCanonical identity | Open web | Not recorded | Rights not recorded, link only | 4 claims | |
| E2 | Cabaletta Bio, Inc. DEF 14A 2025-05-13SEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 6 claims | ||
| E3 | CABA DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E4 | CABA DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E5 | CABA DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E6 | CABA DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E7 | CABA DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E8 | Auditboard_seats. Board seats | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 3 claims |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.
- Control and voting
- Governance
- Risk
- AI oversight
- Legal
- Compensation
Index memberships
No current membership is published in Alpha's tracked index universe.
This is not evidence that the company is absent from every market index.
As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Coverage states the record reports (12)
- Corporate structure
- Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- Ownership
- Not reviewed. Ownership and voting power determine who can influence the board.
- Financials
- Not reviewed. Governance-relevant financial context frames capital and audit decisions.
- Compensation
- Not reviewed. Pay design shows how incentives are governed.
- Governance
- Not reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governance
- Not reviewed. Meeting and vote records show shareholder dissent and support.
- Audit
- Not reviewed. Auditor, controls and restatements show assurance over reporting.
- Legal
- Not reviewed. Material legal and regulatory matters show enforcement exposure.
- Risk
- Not reviewed. Risk ownership links the board, committees, executives and controls.
- Cyber
- Not reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governance
- Not reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets external
- Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
History
Version public-1Published .
- CFO role recorded. Anup Marda executive of Cabaletta Bio, Inc., effective 28 Apr 2026.Effective . Recorded .
- Executive appointed. Arun Das, M.D. executive of Cabaletta Bio, Inc., effective 28 Apr 2026.Effective . Recorded .
- Gc role recorded. Michael Gerard executive of Cabaletta Bio, Inc., effective 28 Apr 2026.Effective . Recorded .
- Executive appointed. Steve Gavel executive of Cabaletta Bio, Inc., effective 28 Apr 2026.Effective . Recorded .
- CEO role recorded. Steven Nichtberger, M.D. executive of Cabaletta Bio, Inc., effective 28 Apr 2026.Effective . Recorded .
- Director appointed. Shawn Tomasello, MBA seat on Cabaletta Bio, Inc., effective 2023.Effective . Recorded .
- Director appointed. Scott Brun, M.D. seat on Cabaletta Bio, Inc., effective 2021.Effective . Recorded .
- Director appointed. Catherine Bollard, MBChB, M.D. seat on Cabaletta Bio, Inc., effective 2019.Effective . Recorded .
- Director appointed. Richard Henriques, MBA seat on Cabaletta Bio, Inc., effective 2019.Effective . Recorded .
- Committee created. Audit · Chair committee of Cabaletta Bio, Inc., effective 2019.Effective . Recorded .
- Committee member added. Richard Henriques, MBA member of Audit · Chair, effective 2019.Effective . Recorded .
- Director appointed. Mark Simon, MBA seat on Cabaletta Bio, Inc., effective 2018.Effective . Recorded .
- Committee member added. Mark Simon, MBA member of Audit, effective 2018.Effective . Recorded .
- Director appointed. Steven Nichtberger, M.D. seat on Cabaletta Bio, Inc., effective 2017.Effective . Recorded .
About this record
- Alpha ID
- alpha:company:b720a7d2-bfe6-459b-89ac-10b754d679aa
- Version
- public-1:ro-d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Source reported
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Published company record built from public sources
- Never published
- Private company data: deployments, authority grants, TrustChecks, receipts, telemetry
The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.

